| 产品详情 |
| Edit |   |
|---|
| Product Name | CID 16020046 |
|---|
| Description | Selective GPR55 antagonist. Inhibits LPI-induced Ca2+ signaling (IC50 = 0.21 μM in HEK-GPR55 cells), ERK1/2 phosphorylation and GPR55-mediated transcription factor activation. Displays weak inhibition of acetylcholinesterase, μ-opioid receptor, KCNH2 and hERG. Decreases LPI-induced GPR55 internalization. Reduces experimental intestinal inflammation in mice. Purity 99%. MW (observed): 425.44 |
|---|
| Size | 5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 4-[4,6-Dihydro-4-(3-hydroxyphenyl)-3-(4-methylphenyl)-6-oxopyrrolo[3,4-c]pyrazol-5(1H)-yl]benzoic acid |
|---|
| Gene, Accession, CAS # | CAS: 834903-43-4 |
|---|
| Catalog # | 4959/5 |
|---|
| Price | |
|---|
| Order / More Info | CID 16020046 from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | PubMed: 25989290, 28552522, 28779174, 28800762 |
|---|
| 产品资料 |
|
|